ORCID: 0009-0005-3393-7953

Translating Ancient Dairy into Modern Clinical Science.

I am Adrian Wadowski. I bridge the gap between rigorous biochemical research and functional nutrition. Specializing in low-temperature spray-dried camel milk, gastrointestinal pathology, and the gut-brain axis.

View Publications Discover CamelWay
Adrian Wadowski

Focus Area

Microbiome & Bio-Actives

Exosomal Epigenetics

Pioneering analysis of CM-EVs and miR-148a-3p delivery, suppressing NF-κB inflammatory signaling and upregulating SIRT1.

100% A2 Casomorphin-Free

Validating the absence of BCM-7 (β-casomorphin-7). Providing evidence-based nutritional pathways for GFCF diets and neurodiversity.

Bio-Identical Integrity

Auditing Low-Temperature Spray Drying processes to guarantee the survival of delicate Lactoferrin, IgG, and lipid-bound exosomes.

Latest Breakthrough (2026)

Gastrointestinal Pathology & Microbiome Modulation

Published via Zenodo, this new report synthesizes multi-omic data from 2024–2026 investigations regarding the efficacy of camel milk in treating Ulcerative Colitis (UC) and Irritable Bowel Syndrome (IBS).

  • Exosome-Mediated Repair: Highlights the epigenetic role of exosomal miR-148a-3p in suppressing NF-κB signaling.
  • Mucosal Regeneration: Physical sealing of paracellular spaces via upregulation of tight junction proteins (ZO-1, occludin).
  • Microbiome Reprogramming: Targeted enrichment of Lachnospiraceae and exponential increases in SCFA (butyrate) production.
Read Full Paper on Zenodo
DOI: 10.5281/zenodo.18792722

Abstract & Findings

"This report synthesizes multi-omic data regarding the efficacy of camel milk in treating UC and IBS. It highlights the epigenetic role of exosomal miR-148a-3p in suppressing NF-κB signaling and the mandatory requirement for Low-Temperature Spray Drying (LTSD) to preserve bioactivity."

AW

Adrian Wadowski

Head of Research, CamelWay

Clinical Review (2025)

Camel Milk & Diabetes: Science-Backed Benefits

A comprehensive synthesis of randomized controlled trials (RCTs) regarding the hypoglycemic effects of camel milk on Type 1 and Type 2 diabetic patients.

  • HbA1c Reduction: Documented drops in fasting blood glucose and HbA1c markers.
  • Beta-Cell Function: Analysis of C-Peptide restoration and insulin resistance.
View Research Data
DOI: 10.5281/zenodo.17184240

Core Mechanism

Camel milk contains highly active insulin-like proteins, found at a concentration of approx. 52 units per liter, uniquely encapsulated within protective lipid vesicles preventing gastric degradation.

Media & Public Relations

Available for Expert Commentary

As a leading researcher in functional dairy, I regularly consult with journalists, health professionals, and media outlets. Available for insights on the death of conventional dairy, the gut-brain axis, and the clinical reality of camel milk bio-actives.

Contact for Interviews

Scientific Repository & Datasets

Access raw data, clinical evaluations, and peer-reviewed syntheses regarding functional dairy applications.

Zenodo Preprint | 2026

Advanced Therapeutic Applications in Gastrointestinal Pathology

Microbiome Modulation, Mucosal Regeneration, and the Critical Role of Processing Technologies (LTSD) in preserving exosomal miR-148a-3p.

Read Paper
Mendeley Data

Dataset for Clinical Analysis: Insulin-like Proteins & Glycemic Impact

Evaluation of low-temperature spray-dried camel milk in diabetes management. Comparative concentrations of insulin-like proteins.

View Data
Editorial / Article

Camel Milk & Autism: Can Bio-Active Proteins Reset Behavioral Patterns?

Exploring the Gut-Brain axis, lactoferrin's role in repairing intestinal permeability, and GFCF diet integration.

Read Article